Vismodegib for treatment of periocular basal cell carcinoma - 6-year experience from a tertiary cancer center,
Abstract Background: The treatment of advanced periocular basal cell carcinomas becomes a challenge as surgery may involve highly mutilating procedures. Vismodegib is the first selective hedgehog inhibitor approved for the treatment of locally advanced tumors or metastatic disease. Objective: Analyz...
में बचाया:
मुख्य लेखकों: | , , , , , |
---|---|
स्वरूप: | पुस्तक |
प्रकाशित: |
Sociedade Brasileira de Dermatologia,
2022-01-01T00:00:00Z.
|
विषय: | |
ऑनलाइन पहुंच: | Connect to this object online. |
टैग: |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|
इंटरनेट
Connect to this object online.3rd Floor Main Library
बोधानक: |
A1234.567 |
---|---|
प्रति 1 | उपलब्ध |